Correction: EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.

Correction: EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.

Bibliographic Details
Main Authors:	Helen Schneck, Berthold Gierke, Frauke Uppenkamp, Bianca Behrens, Dieter Niederacher, Nikolas H Stoecklein, Markus F Templin, Michael Pawlak, Tanja Fehm, Hans Neubauer, Disseminated Cancer Cell Network (DCC Net) Duesseldorf
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4747539?pdf=render

Similar Items

EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
by: Helen Schneck, et al.
Published: (2015-01-01)

EpCAM as Modulator of Tissue Plasticity
by: François Fagotto
Published: (2020-09-01)

Expression of EpCAM in uveal melanoma
by: Odashiro Alexandre N, et al.
Published: (2006-11-01)

Current View on EpCAM Structural Biology
by: Aljaž Gaber, et al.
Published: (2020-05-01)

Evolution of Thyroglobulin Loop Kinetics in EpCAM
by: Serena H. Chen, et al.
Published: (2021-09-01)

EpCAM expression in squamous cell carcinoma of the uterine cervix detected by monoclonal antibody to the membrane-proximal part of EpCAM
by: Chantima, W, et al.
Published: (2017)

Correction to: EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
by: Nithya Subramanian, et al.
Published: (2020-11-01)

EpCAM expression in squamous cell carcinoma of the uterine cervix detected by monoclonal antibody to the membrane-proximal part of EpCAM
by: Warangkana Chantima, et al.
Published: (2017-12-01)

EpCAM knockdown alters microRNA expression in retinoblastoma--functional implication of EpCAM regulated miRNA in tumor progression.
by: Madhu Beta, et al.
Published: (2014-01-01)

Tufting enteropathy with EpCAM mutation: case report
by: Karla Lais Pêgas, et al.
Published: (2014-06-01)

Correction: EpCAM knockdown alters microRNA expression in retinoblastoma--functional implication of EpCAM regulated miRNA in tumor progression.
by: PLOS ONE Staff
Published: (2015-01-01)

274 CD47 x EpCAM bispecific antibody represents a novel approach for treating EpCAM overexpressing solid tumors
by: Xinhua Wang, et al.
Published: (2021-11-01)

EpCAM and gpA33 are markers of Barrett's metaplasia.
by: Wong, N, et al.
Published: (2006)

EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs
by: Joanna Macdonald, et al.
Published: (2018-01-01)

EpCAM as a novel therapeutic target for hepatocellular carcinoma
by: Vasanthakumar S, et al.
Published: (2017-07-01)

Clinicopathology of EpCAM and EGFR in human epithelial ovarian carcinoma
by: Zheng Jingying, et al.
Published: (2017-03-01)

Selection and targeting of EpCAM protein by ssDNA aptamer.
by: Walhan Alshaer, et al.
Published: (2017-01-01)

Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model
by: Tianqi Xu, et al.
Published: (2021-08-01)

CRISPR/Cas9 disruption of EpCAM Exon 2 results in cell-surface expression of a truncated protein targeted by an EpCAM specific T cell engager
by: Andisheh Bagheri, et al.
Published: (2022-03-01)

EpCAM-Binding DARPins for Targeted Photodynamic Therapy of Ovarian Cancer
by: Dirk van den Brand, et al.
Published: (2020-07-01)

Targeted EpCAM-binding for the development of potent and effective anticancer proteins
by: Zhao Liu, et al.
Published: (2023-05-01)

EpCAM-targeting CAR-T cells against hepatoma cells in vitro
by: WANG Song, et al.
Published: (2023-09-01)

Leukocyte-Derived Extracellular Vesicles in Blood with and without EpCAM Enrichment
by: Afroditi Nanou, et al.
Published: (2019-08-01)

Initial activation of EpCAM cleavage <it>via </it>cell-to-cell contact
by: Bärr Gabriele, et al.
Published: (2009-11-01)

EpCAM as a Novel Biomarker for Survivals in Prostate Cancer Patients
by: Yang Liao, et al.
Published: (2022-04-01)

Simulation and Stability Assessment of Anti-EpCAM Immunotoxin for Cancer Therapy
by: Seyed-Ali Hosseinian, et al.
Published: (2018-08-01)

Correction: Selection and targeting of EpCAM protein by ssDNA aptamer.
by: Walhan Alshaer, et al.
Published: (2018-01-01)

Dataset and analysis of molecular dynamics simulation of EpCAM ectodomain dimer
by: Miha Pavšič
Published: (2021-10-01)

Destabilization of EpCAM dimer is associated with increased susceptibility towards cleavage by TACE
by: Tomaž Žagar, et al.
Published: (2021-05-01)

Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition
by: Taylor C. Brown, et al.
Published: (2021-06-01)

Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications
by: Guanjie Li, et al.
Published: (2022-06-01)

Characterization of human anti-EpCAM antibodies for developing an antibody–drug conjugate
by: Hiroyuki Satofuka, et al.
Published: (2023-03-01)

Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside
by: Yiyang Liu, et al.
Published: (2022-11-01)

Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinoma
by: Takehiro Hayashi, et al.
Published: (2017-10-01)

Abnormal placental development and early embryonic lethality in EpCAM-null mice.
by: Keisuke Nagao, et al.
Published: (2009-12-01)

EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer.
by: Nithya Subramanian, et al.
Published: (2015-01-01)

EpCAM-claudin-tetraspanin-modulated ovarian cancer progression and drug resistance
by: Zehra Tavsan, et al.
Published: (2020-01-01)

222-L Pemigatinib increases the effectiveness of EpCAM-CAR-T in squamous cell carcinoma
by: Xiaoyu Zhang, et al.
Published: (2023-11-01)

Gene delivery to breast cancer by incorporated EpCAM targeted DARPins into AAV2
by: Ya-feng Lv, et al.
Published: (2023-12-01)

Potent and selective eradication of tumor cells by an EpCAM-targeted Ras-degrading enzyme
by: Valentina Palacio-Castañeda, et al.
Published: (2023-09-01)